title: Oncologic Care and Pathology Resources in Africa: Survey and Recommendations.
abstract: The connection of a clinician who identifies a patient with signs and symptoms of malignancy to an oncologist who has the tools to treat a patient's cancer requires a diagnostic pathology laboratory to receive, process, and diagnose the tumor. Without an accurate classification, nothing is known of diagnosis, prognosis, or treatment by the clinical team, and most important, the patient is left scared, confused, and without hope. The vast majority of deaths from malignancies occur in sub-Saharan Africa primarily as a result of lack of public awareness of cancer and how it is diagnosed and treated in the setting of a severe lack of resources (physical and personnel) to actually diagnose tumors. To correct this massive health disparity, a plan of action is required across the continent of Africa to bring diagnostic medicine into the modern era and connect patients with the care they desperately need. We performed a survey of resources in Africa for tissue diagnosis of cancer and asked quantitative questions about tools, personnel, and utilization. We identified a strong correlation between pathology staffing and capacity to provide pathology services. On the basis of this survey and through a congress of concerned pathologists, we propose strategies that will catapult the continent into an era of high-quality pathology services with resultant improvement in cancer outcomes.
authors.affiliation: Ann M. Nelson, Joint Pathology Center, Silver Spring, MD; Danny A. Milner, Harvard Medical School and Harvard School of Public Health, Boston, MA; Timothy R. Rebbeck, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA; and Yawale Iliyasu, Ahmadu Bello University, Zaria, Nigeria.
authors.forename: Ann M
authors.initials: AM
authors.lastname: Nelson
authors.affiliation: Ann M. Nelson, Joint Pathology Center, Silver Spring, MD; Danny A. Milner, Harvard Medical School and Harvard School of Public Health, Boston, MA; Timothy R. Rebbeck, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA; and Yawale Iliyasu, Ahmadu Bello University, Zaria, Nigeria.
authors.forename: Danny A
authors.initials: DA
authors.lastname: Milner
authors.affiliation: Ann M. Nelson, Joint Pathology Center, Silver Spring, MD; Danny A. Milner, Harvard Medical School and Harvard School of Public Health, Boston, MA; Timothy R. Rebbeck, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA; and Yawale Iliyasu, Ahmadu Bello University, Zaria, Nigeria. timothy_rebbeck@dfci.harvard.edu.
authors.forename: Timothy R
authors.initials: TR
authors.lastname: Rebbeck
authors.affiliation: Ann M. Nelson, Joint Pathology Center, Silver Spring, MD; Danny A. Milner, Harvard Medical School and Harvard School of Public Health, Boston, MA; Timothy R. Rebbeck, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA; and Yawale Iliyasu, Ahmadu Bello University, Zaria, Nigeria.
authors.forename: Yawale
authors.initials: Y
authors.lastname: Iliyasu
mesh_terms: D000349:Africa; D006801:Humans; D009369:Neoplasms / Q000473:pathology* / Q000628:therapy*; D011795:Surveys and Questionnaires